Jacqueline Brandwynne
Vorstandsvorsitzender bei Brandwynne Corp.
Profil
Ms. Jacqueline Brandwynne is President & Chief Executive Officer at Brandwynne Corp.
and an Advisor at Proteus Venture Partners LLC (Venture Capital).
She is on the Board of Directors at Cedars Sinai Health System and California Institute of the Arts.
Ms. Brandwynne was previously employed as Independent Director by ImmunoCellular Therapeutics Ltd.
She also served on the board at MicroVision, Inc. and Pacific Union Bank.
Aktive Positionen von Jacqueline Brandwynne
Unternehmen | Position | Beginn |
---|---|---|
Brandwynne Corp. | Vorstandsvorsitzender | 22.02.2011 |
California Institute of the Arts | Direktor/Vorstandsmitglied | 22.02.2011 |
Ehemalige bekannte Positionen von Jacqueline Brandwynne
Unternehmen | Position | Ende |
---|---|---|
Pacific Union Bank (California) | Direktor/Vorstandsmitglied | 15.01.2013 |
EOM PHARMACEUTICALS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 24.09.2012 |
MICROVISION, INC. | Direktor/Vorstandsmitglied | 28.02.2006 |
Cedars Sinai Health System
Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | - |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Berater | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MICROVISION, INC. | Electronic Technology |
Private Unternehmen | 5 |
---|---|
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
Brandwynne Corp. | |
Pacific Union Bank (California) | Finance |
Cedars Sinai Health System
Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |